Search results
Mapped: The cheapest places to buy a house in the UK according to new study
The Independent via Yahoo News· 36 minutes agoBarclays, HSBC, NatWest, Accord...dramatic reversal from its November forecast, which said they...
Stock Market Modestly Higher As Dow Leads; AI Stock Palantir Plunges After Earnings
Investor's Business Daily· 46 minutes agoThe company now plans to use generative AI to spur growth in the commercial market. Datadog gapped...
Best Stocks To Buy And Watch Now: CrowdStrike Headlines 5 Top Tech Stocks For May
Investor's Business Daily· 42 minutes agoWhen the company reported earnings in April, it returned to bottom-line and top-line growth after...
Investors Heavily Search SM Energy Company (SM): Here is What You Need to Know
Zacks via Yahoo Finance· 2 hours agoSo, it might be a good idea to review some of the factors that might affect the near-term...
Medicare Advantage pluses could be cut in 2025
Consumer Affairs· 23 minutes agoDespite lower reimbursement rates from Centers for Medicare & Medicaid Services (CMS) and higher medical costs, many Advantage (aka Part C) plan leaders said they will focus on margins over ...
Target upgraded, CVS downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 1 hour agoWolfe Research upgraded Insulet (PODD) to Outperform from Peer Perform with a $200 price target. The...
Why SoundHound AI Stock Plunged 28% Last Month
Motley Fool via Yahoo Finance· 2 hours agoIn early 2023, SoundHound took out a term loan with a rate that fluctuates. As of Dec. 31, the interest rate was roughly 14%. It had $84 million...
BILL’s (BILL) Buy Rating Reaffirmed at Needham & Company LLC
ETF DAILY NEWS· 12 hours agoNeedham & Company LLC restated their buy rating on shares of BILL (NYSE:BILL – Free Report) in a research report sent to investors on Friday, Benzinga reports. Citigroup boosted ...
Lyra Therapeutics shares down 13% after trial failure; BofA downgrades rating By Investing.com
Investing.com· 3 hours agoOn Tuesday, BofA Securities adjusted its stance on Lyra Therapeutics (NASDAQ:LYRA), moving from a...
Mortgage Rates Aren't the Only Hurdle for Homebuyers. There Aren't Enough Houses
CNET· 40 minutes agoDepending on who you ask, the biggest obstacle for homebuyers is either mortgage rates, home prices or inventory. In a balanced housing market, there are typically five to six months of supply ...
